You have no items in your shopping cart.
Cart summary
Recombinant Human VEGF165 (His Tag)
Catalog Number: orb1921837
| Catalog Number | orb1921837 |
|---|---|
| Category | Proteins |
| Description | VEGF165 Protein, Human (P.pastoris) is a Vascular Endothelial Growth Factor A (VEGF-A) isoform. VEGF is a heparin-binding growth factor specific for vascular endothelial cells that is able to induce angiogenesis. |
| Form/Appearance | Lyophilized Powder |
| Purity | ≥95% |
| MW | 20.1kDa |
| Entrez | 7422 |
| UniProt ID | P15692 |
| Source | CHO Cell |
| Expression System | Eukaryotic cell |
| Biological Origin | Human |
| Endotoxins | ≤10 EU/mg |
| Storage | Use a manual defrost freezer and avoid repeated freeze - thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -86°C under sterile conditions after reconstitution. |
| Alternative names | VEGF-AA; rHuVEGF165; VPF; Folliculostellate cell-d Read more... |
| Note | For research use only |
| Application notes | Application Notes: For research use only. Minimum Sample Size: 50μg/vial |
| Expiration Date | 6 months from date of receipt. |
Recombinant Human VEGFA Protein, C-His [orb1088542]
CLIA, EIA, LF
> 90% as determined by SDS-PAGE
20.8 kDa
HEK293
1 mgVEGF121 Protein, Human, Recombinant (His & Avi), Biotinylated [orb1960084]
98.00%
17 kDa (predicted). Due to glycosylation, the protein migrates to 18 kDa and 22-25 kDa under reduced (R) condition, 30 kDa and 32-40 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.
500 μg, 100 μg, 1 mgVEGF121 Protein, Human, Recombinant (His & Avi) [orb1960085]
98.00%
17 kDa (predicted). Due to glycosylation, the protein migrates to 18 kDa and 22-25 kDa under reduced (R) condition, 30 kDa and 32-40 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.
500 μg, 100 μg, 1 mgVEGF165 Protein, Human, Recombinant (His & Avi) [orb1960086]
> 95%
22.2 kDa (predicted). Due to glycosylation, the protein migrates to 28-35 kDa under reduced (R) condition, 45-60 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.
1 mg, 100 μg, 500 μgVEGF165 Protein, Human, Recombinant (His & Avi), FITC-Labeled [orb1960087]
> 95%
22.2 kDa (predicted). Due to glycosylation, the protein migrates to 28-33 kDa under reduced (R) condition, 45-55 kDa under Non reducing (N) condition based on Tris-Bis PAGE result.
1 mg, 500 μg, 100 μg
